Most Read News

Retail investors made up 47% of the subscribers, NII made up 11% of the bookings, and QIB has not yet been booked. There were 3.83 subscriptions for the employee section.

The IPO comprises a mix of a fresh issue of ₹175 Crore worth of shares and an offer-for-sale (OFS) of 17.5 lakh equity shares worth ₹125.13 Crore at the upper price band.

Aurobindo Pharma was trading at ₹1,019.75 on the BSE at 14:13 pm, down ₹25.40, or 2.43%.

Among the top losers on the Nifty were Adani Enterprises, Coal India, Adani Ports, Power Grid Corporation, and NTPC, while notable gainers included ITC, UltraTech Cement, HCL Technologies, Kotak Mahindra Bank, and ICICI Bank.

Today, Tata Motors, ITC, L&T Finance Holdings, Power Mech Projects, Adani Green Energy may see movement in stock prices.

The biggest loser was Adani Green Energy, which fell 13% to an intraday low of ₹1,650 a share on the NSE.

On the global front, The S&P 500 and Nasdaq fell on Wednesday as investors grabbed gains in chipmaker companies.

the third day of the bidding, the portion for retail investors was subscribed 17.44 times, the piece for qualified institutional buyers (QIBs) was booked 46.33 times, and the portion for NIIs was booked 32.09 times.

Subscription data revealed that qualified institutional buyers led the charge, subscribing 17.50 times the allotted quota, followed by non-institutional investors who subscribed 9.5 times their reserved portion. Retail investors also showed interest, bidding 4.01 times the reserved portion, while employees exhibited aggressive bidding, subscribing 6.88 times their set-aside portion.

During the ban period, no fresh positions are permitted for any F&O contracts of the specified stocks.